More on SNOA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+68.8% Growth)
- Ratings (6.7 Score)

Upcoming Events

- Earnings (11/16/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Sonoma Pharmaceuticals (NQ:SNOA)
Delayed: 1.13 -0.07 (5.83%)
Prev. Close $1.20  
Open$1.16 
52 Wk High$ 
52 Wk Low$ 
Day High$1.18 
Day Low$1.13 
P/E N/A  
EPS$ 
Volume12,473 

Friends, Peers and Foes (?): RNA (more...)

Oct 6, 2026 04:34 PM Form 8-A12B/A Sonoma Pharmaceuticals,
Oct 6, 2026 04:30 PM Form 8-K Sonoma Pharmaceuticals, For: Oct 06
Sep 17, 2026 06:02 AM Form 8-K Sonoma Pharmaceuticals, For: Sep 16
Aug 19, 2026 05:27 PM Form 8-K Sonoma Pharmaceuticals, For: Aug 19
Aug 6, 2026 09:20 AM Sonoma Pharmaceuticals (SNOA) Tops Q1 EPS by 21c
Aug 6, 2026 09:01 AM Sonoma Pharmaceuticals posts 60% revenue rise, first positive EBITDA
Aug 6, 2026 09:01 AM Sonoma Pharmaceuticals Delivers 141% U.S. Revenue Growth in FY Q1, 60% Total Revenue Growth and First-Ever Positive Adjusted EBITDA
Aug 6, 2026 08:31 AM Form 10-Q Sonoma Pharmaceuticals, For: Jun 30
Jul 28, 2026 04:50 PM Form DEF 14A Sonoma Pharmaceuticals, For: Sep 16
Jul 23, 2026 06:02 AM Form DEFA14A Sonoma Pharmaceuticals,
View All Articles

Entities mentioned with SNOA

View All Entities